Description

About Us:

Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support an extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians want to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the DiffuSphere™ technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia's DiffuSphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, also to be applicable in oncology, infectious disease and other critical disease areas.

Eupraxia's EP-104GI is currently in a Phase 1b/2 trial, the RESOLVE trial, for the treatment of EoE. EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. This is a unique treatment approach for EoE. Eupraxia also recently completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. The trial met its primary endpoint and three of the four secondary endpoints. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company's website at: www.eupraxiapharma.com.

Job Description: 

Eupraxia Pharmaceuticals is seeking a dynamic and experienced Vice President of Marketing and Commercial Strategy with extensive experience creating marketing strategies, launching new products and driving commercial pipeline strategy. This individual will be responsible for developing all marketing strategies, focusing initially on launch readiness and commercialization in the U.S. of the lead program EP-104GI for Eosinophilic Esophagitis (EoE). As one of the first commercial hires, this position will be integral in Eupraxia's transition to a commercial stage biotechnology company.

Key Responsibilities:

Strategic Marketing, Pre-Launch Planning  

• Lead the development of the 3-year strategic commercial plan, ensuring alignment between Clinical, Regulatory, and Medical Affairs to support a successful launch in the US and potentially global markets.
• Analyze qualitative and quantitative market data to generate a deeper understanding of the customer's needs, brand and disease issues and market potential. 
• Develop and implement overarching marketing strategy (brand plan) to define product positioning, support clinical development, and enhance brand awareness.
• Effectively communicate core branding, marketing messages and product positioning statements within the organization.
• Develop the optimal field force sizing, structure, and territory alignment models.

Brand Management

• Manage global brand marketing budget, individual project budgets and develop annual and long-range sales and expense forecasts.
• Advise on annual planning, priority setting and budget allocation. 
• Monitors business results against stated objectives and initiates corrective actions.

Market Access & Pricing Support

• Collaborate with Market Access vendors, and eventually internal Market Access leadership to support the appropriate Phase 3 strategy and operational planning to ensure optimal PRMA and HEOR conditions for Phase 3 trails, NDA approval and product launch. 
• Support the development of the Health Technology Assessment and equivalent dossiers and value decks for payer presentations, ensuring clinical data is translated into economic value.

Data, Analytics & Competitive Intelligence

• Establish the commercial analytics function, including forecasting, patient journey mapping, and performance dashboards. Secure necessary data contracts (claims data, Rx data) to track market uptake and patient switching patterns.
• Oversee global product demand forecasts for manufacturing.
• Maintain a deep understanding of the GI/EoE landscape, monitoring competitor data readouts, pricing strategies, and standard-of-care shifts to adapt our commercial tactics in real-time.

Cross-Functional Collaboration

• Responsible for coordinating the activities and resource planning of the global Market Access, Market Research, Patient Advocacy, and Medical groups, as different teams are added, to align to the global strategy and execution of the business plan.
• Partner with R&D, Clinical, Sales, Market Access, and Medical Affairs to convey consistent messaging and commercial goals.

Stakeholder Engagement

• Build relationships with Key Opinion Leaders (KOLs), patient advocacy groups, and customers.

Lifecycle Management

• Oversee end-to-end launch planning, marketing, and promotional strategies for new and existing assets.

Requirements

Requirements

• Bachelors’ degree in Business, Life Sciences or related field; MBA or PhD is an asset.
• 15+ years of commercial experience in the biotech/pharmaceutical industry, with at least 5 years in a leading marketing role. Preferable to have both US and global experience
• Role knowledge: Experience in sales and marketing, market strategy, launch planning, market analytics, pricing, re-imbursement and market access (PRMA)
• Industry Knowledge: Understanding of the healthcare ecosystem, including clinical workflows, regulatory landscapes, reimbursement environments, and therapeutic areas (e.g., GI, Immunology and/or specialty therapeutics). A proven track record in a launch of a specialty therapeutic. Experience in Gastroenterology (GI), Immunology, or Rare Disease is highly preferred
• Experience with forecast modeling, budget management (P&L), CRM implementation, and vendor management (agencies, data providers)

Additional attributes

• Highly motivated self-starter with strong initiative in identifying operational improvements
• Clear communicator capable of presenting to senior management, and key external stakeholders
• Proactive problem-solver who can troubleshoot equipment issues and safety concerns independently
• Excellent organizational and time management skills to juggle multiple priorities
• Excellent written, organizational, and analytical skills.
• Continuous learner committed to staying current with development in Eupraxia’s strategic areas of interest (GI disease and EoE)
• Strong vendor and supplier relationship management skills
• Able and willing to travel internationally, especially between Canada, the US and Europe.